Awards & Advancement

Kibow Biotech is a "Buzz of BIO" award winner

Thursday, June 19, 2014 02:52 PM

Kibow Biotech is winner of a 2014 BIO International Convention "Buzz of BIO Award," and is the first biotechnology company specializing exclusively in dietary supplement products to receive the honor during BIO's 29-year history. BIO is the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and more than 30 other nations. BIO member companies are involved in the R&D of innovative healthcare, agricultural, industrial and environmental biotechnology products.

More... »


Sorbent Therapeutics appoints two new board members

Thursday, June 19, 2014 02:27 PM

Sorbent Therapeutics, a biopharmaceutical company developing therapies for cardiovascular and renal diseases, has appointed Jay Shepard and William D. Waddill to the company's board of directors.

More... »


Sangamo BioSciences appoints H. Stewart Parker to its board of directors

Thursday, June 19, 2014 01:57 PM

Sangamo BioSciences announced the appointment of H. Stewart Parker to the company's board of directors. Parker, who founded and was president and CEO of Targeted Genetics, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy.

More... »

CSSi appoints Ronald Bukowski to New Medical and Clinical Advisory Board

Thursday, June 12, 2014 01:02 PM

CSSi, a provider of patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board (MCAB) and the appointment of Ronald M. Bukowski, M.D., as its chairman.

More... »

Kite Pharma appoints William Y. Go, Jeff Aycock senior directors

Thursday, June 12, 2014 12:54 PM

Kite Pharma, a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT) products for the treatment of cancer, has expanded Kite's R&D leadership team with the appointments of William Y. Go, M.D., Ph.D., as senior director, Clinical Development, and Jeff Aycock as senior director, Clinical Operations.

More... »

OptiNose adds three to operations, regulatory affairs and commercialization

Thursday, June 12, 2014 12:34 PM

OptiNose, a global specialty pharmaceuticals company, has announced three appointments to the company's senior management team.

More... »

Andrew S. Kraft named director of University of Arizona Cancer Center

Monday, June 9, 2014 10:44 AM

Dr. Andrew S. Kraft, a prostate cancer physician-scientist and cancer center administrator, has been named the Sydney E. Salmon endowed chair and director of the University of Arizona Cancer Center and associate vice president for oncology programs for the UA Health Sciences Center. In addition, Kraft joins the University as a tenured professor of medicine in the department of Medicine's Division of Hematology/Oncology and senior associate dean for translational research in the College of Medicine.

More... »

Quintiles named to 2014 CIO 100

Friday, June 6, 2014 01:53 PM

Quintiles has been named to the 2014 CIO 100. Each year, CIO magazine identifies and honors 100 organizations that have distinguished themselves by creating business value through the effective and innovative use of IT.

More... »

Ampio Pharmaceuticals appoints Gregory A. Gould CFO

Friday, June 6, 2014 01:50 PM

Ampio Pharmaceuticals has appointed Gregory A. Gould chief financial officer, treasurer and corporate secretary. Gould, a veteran of the pharmaceutical and life sciences industry, is joining the company effective June 10. Mark McGregor, the company's current chief financial officer, will retire from Ampio Pharmaceuticals following a transition period later this year.

More... »

Court recognizes majority of Viropro shareholders' election of new board of directors

Friday, June 6, 2014 01:34 PM

Viropro, a Nevada corporation that was formed to specialize in contract research, development and manufacturing of biotherapeutic proteins for including cancer, diabetes, inflammation and hepatitis, has a new board of directors as a result of an order of the Supreme Court of the State of New York in a challenge by a majority of the Viropro shareholders to the management of Viropro.

More... »

Subscribe to The CenterWatch Monthly
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs